<?xml version="1.0" encoding="UTF-8"?>
<p>Therapies that have been used for treatment of patients infected with MERS-CoV include convalescent sera, corticosteroids, and/or antiviral therapeutics including interferons, ribavirin, and protease inhibitors (or combination of members from these groups)(
 <xref rid="ref8" ref-type="bibr">Al-Tawfiq et al., 2014</xref>; 
 <xref rid="ref115" ref-type="bibr">Petersen et al., 2015</xref>; 
 <xref rid="ref173" ref-type="bibr">Zumla et al., 2016</xref>; 
 <xref rid="ref7" ref-type="bibr">Al-Tawfiq and Memish, 2017</xref>; 
 <xref rid="ref104" ref-type="bibr">Mustafa et al., 2018</xref>). There is a long list of potential therapeutics in preclinical phase that have shown promising results 
 <italic>in vitro</italic> and in animal models. Comprehensive reviews of the current therapeutics under development have been published elsewhere (
 <xref rid="ref173" ref-type="bibr">Zumla et al., 2016</xref>; 
 <xref rid="ref44" ref-type="bibr">Dyall et al., 2017</xref>; 
 <xref rid="ref119" ref-type="bibr">Rabaan et al., 2017</xref>).
</p>
